“49. A SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF PD-(L)1 INHIBITORS FOR FIRST-LINE TREATMENT AMONG PATIENTS WITH HIGH PD-L1 EXPRESSION NON-SMALL CELL LUNG CANCER”, YHCĐ, tập 65, số Tiếng Anh, thg. 12 2024, doi: 10.52163/yhc.v65i13.1891.